GlassScriptPhysician profile
Jacky D Shannon
NPI 1265510218
$2,496.56
in general payments reported to CMS, 2019-2025
26 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Critical Care Medicine (Anesthesiology) provider received nationally (typical 2025 total: $97.90).
See the full distribution for Critical Care Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $270 · 2021: $592 · 2022: $277 · 2023: $307 · 2024: $779 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $827.33 | 2021-2025 | Impella |
| Grifols USA, LLC | $375.43 | 2020-2024 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $162.04 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.18 | 2019-2024 | Spiriva Respimat, Ofev |
| Nuwellis, INC. | $118.98 | 2021 | |
| Janssen Pharmaceuticals, INC | $113.94 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $105.93 | 2019-2024 | Fasenra |
| Abbott Laboratories | $100.76 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Merck Sharp & Dohme LLC | $57.67 | 2019-2024 | Bridion |
| Mylan Specialty L.P. | $50.04 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $43.01 | 2020-2021 | |
| Amgen INC. | $42.22 | 2022-2024 | Tezspire |
| Ucb, INC. | $40.66 | 2021-2024 | Briviact |
| Baxter Healthcare | $37.07 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $36.12 | 2021-2024 | Tyvaso |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $28.71 | 2020 | |
| Abbvie INC. | $26.97 | 2021-2022 | |
| Penumbra, INC. | $25.94 | 2024 | Indigo System |
| Ambu INC. | $24.52 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $24.39 | 2024 | Opsumit |
| Pfizer INC. | $20.37 | 2023 | |
| Covidien LP | $20.10 | 2020 | |
| Boston Scientific Corporation | $18.21 | 2023 | Exalt Model D |
| Gilead Sciences, INC. | $17.98 | 2021 | |
| La Jolla Pharmaceutical Company | $16.00 | 2019 | |
| Ge Healthcare | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacky Shannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.